A specific event in the last few hours that changes something — an earnings surprise, a regulatory action, a policy decision, a deal.
Goldman Sachs shares fell after the Federal Reserve's rate decision, even as US banks moved quickly to raise their prime lending rate.
Big US bank stocks fell after the Federal Reserve's latest rate decision, with Goldman Sachs among the decliners even as its CEO flagged softer fixed income, currencies and commodities trading in the third quarter.
Bernstein tells clients to stay bullish on crypto stocks even as the CLARITY Act's failure hit token prices directly.
XRP dropped 10% after the CLARITY Act failed a vote, though Bernstein analysts told clients the setback does not change their bullish view on crypto-linked equities.
Early-stage discussions could see SK Hynix use Intel's US factories to make memory chips, a potential foothold in Intel's stalled foundry turnaround.
Intel stock rose after a report that SK Hynix is in early talks to manufacture memory chips at Intel's U.S. plants.
A deal would mark the first time SK Hynix produces memory chips on US soil, according to people familiar with the talks.
SK Hynix is discussing a potential arrangement with Intel to manufacture memory chips in the United States for the first time, Reuters reported, citing sources familiar with the matter.
The Clarity Act, the industry's top legislative priority, collapsed after last-minute disputes tied to conflict-of-interest concerns around President Trump.
The Senate split over Trump ethics concerns, killing the crypto market-structure legislation the industry had spent record sums lobbying for.
The Clarity Act has not secured enough support to clear its first scheduled Senate procedural hurdle, with both parties holding firm.
The Clarity Act, a bill meant to set clear market-structure rules for crypto, is short of the votes needed to clear its first Senate hurdle absent a late turnaround.
The boat maker beat earnings estimates by three cents a share, with a recent merger adding to the top line.
MasterCraft shares rose 6% after the company beat earnings estimates by $0.03 a share and posted revenue above forecasts, helped by a merger.
Jefferies and BMO both reaffirmed their ratings on Disc Medicine after new data on its polycythemia treatment, with BMO keeping an Outperform call.
Two brokerages reiterated favorable ratings on Disc Medicine following trial data for its polycythemia treatment, a disorder marked by excess red blood cells.
Piper Sandler and Baird both cut their ratings on the contact-lens and medical device maker within the same session, citing soft sales.
Two separate brokerages downgraded Cooper Companies on the same day after the company posted weaker-than-expected sales, a rare show of analyst alignment against the stock.
At least five distinct Silver Lake-linked entities disclosed Dell stock sales within a single reporting window, ranging from under $300,000 to nearly $48 million per filing.
Multiple Silver Lake Partners affiliates that sit on Dell's board disclosed separate stock sales in rapid succession, including one for $48 million and another for $26 million.
The security-analytics firm topped both earnings and revenue forecasts for its latest quarter, beating per-share estimates by 4 cents.
Cognyte Software beat second-quarter earnings expectations by $0.04 per share with revenue also topping estimates, sending shares up 9%.
The brokerage's initiations single out credibility concerns at Klarna while citing growth potential at Affirm and a fintech opportunity at Dave.
Loop Capital initiated coverage on three buy-now-pay-later and fintech names in the same batch, rating Klarna a hold over credibility concerns while starting Affirm and Dave at buy.
The offer values Austal's American shipbuilding business at as much as $1.35 billion, sending the parent's shares sharply higher.
Austal shares rose 6% after a bid worth up to $1.35 billion emerged for the company's U.S. shipbuilding operations.
Crude extended its rally through the September 8 session, with traders citing rising risk of supply disruption from the Middle East.
Brent crude pushed toward $100 a barrel as escalating U.S.-Iran tensions raised fears of a disruption to Middle East oil supply.
The move follows Ottawa's US$20 billion retaliatory tariffs and marks a sharp escalation in the US-Canada trade dispute.
The Trump administration will ban imports of Canadian dairy, alcohol and motor vehicles from September 29, one day after Canada imposed US$20 billion in retaliatory tariffs on US goods.
A failed trial targeting Lp(a), a blood fat linked to heart attacks, dragged down rival drugmakers betting on the same approach.
Novartis's failed trial for a cholesterol-lowering drug that targets Lp(a) sparked a broad selloff across biopharma stocks betting on the same cardiovascular strategy.
The jet-engine giant is buying a key parts supplier as it works to unclog its own production bottlenecks.
GE Aerospace agreed to acquire Consolidated Precision Products (CPP) in a deal valued at roughly $11.75 billion, according to wire reports on the announcement.
Imports jumped 28.2% year-on-year, a faster pace than exports, as the trade data landed just weeks before a planned meeting between Donald Trump and Xi Jinping.
China's exports rose 25% year-on-year in August and imports climbed 28.2%, widening the trade surplus and giving Beijing a stronger hand heading into trade talks with Washington.
The Japanese chip-equipment maker posted a soft first quarter but told investors to expect a record year.
SCREEN Holdings lifted its full-year guidance to a record level even as it reported a soft first quarter for fiscal 2027.
The president says Canada's Bombardier cannot sell planes in the US unless it builds them there, hours before Ottawa's retaliatory tariffs take effect.
President Trump called for a US boycott of Bombardier and said the Canadian planemaker cannot sell aircraft in the US unless it manufactures them domestically.